Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Onion-Pumpkin Extract · 1 trial · 1 indication
Change in Individual SBP Values
Change in Mean SBP Values
Change in Individual DBP Values
Change in Mean DBP Values
| Arm | Type | Description |
|---|---|---|
| Onion-Pumpkin Extract | EXPERIMENTAL | Take two capsules, twice daily before breakfast and dinner |
| Name | Type | Description |
|---|---|---|
| Onion-Pumpkin Extract | DIETARY_SUPPLEMENT | - |
Inclusion Criteria: * BMI ≥ 25 and ≤ 35 kg/m2 * Blood pressure: * SBP: 140-160 mmHg * DBP: 80-90 mmHg * Judged by the Investigator to be in general good health on the basis of medical history * Females of child bearing potential must agree to use appropriate birth control methods during the en...
Onion-Pumpkin Extract is an investigational product being studied for its effects on blood pressure. It is currently in Phase 2 clinical development, with one completed trial that enrolled 10 healthy adult volunteers to evaluate its impact on blood pressure.
Onion-Pumpkin Extract is being developed by Medicus Pharma Ltd., a company traded under the ticker symbol MDCX. The company is conducting clinical research to evaluate the extract's effects on blood pressure.
Onion-Pumpkin Extract is in Phase 2 clinical development. It is an investigational product, not yet approved by regulatory authorities, and is being studied for its potential effects on blood pressure in a completed Phase 2 trial.
Onion-Pumpkin Extract has one completed clinical trial, NCT02353104, titled "The Effects of the Onion-Pumpkin Extract on Blood Pressure." This Phase 2 study enrolled 10 participants, was uncontrolled, and included healthy volunteers aged 18 years and older.
Onion-Pumpkin Extract is not FDA approved. It is an investigational product currently in Phase 2 clinical development, with one completed trial studying its effects on blood pressure. It has not yet received regulatory approval for any use.